Back to Search Start Over

E-cigarette, or vaping, product use Associated Lung Injury (EVALI): new scenarios for physicians and radiologists

Authors :
Carmine Guarino
Ilaria Pedicelli
Francesco Perna
Valentina Di Spirito
Giuseppe Fiorentino
Fabio Procaccini
Gaetano Rea
Source :
Monaldi Archives for Chest Disease (2021)
Publication Year :
2021
Publisher :
PAGEPress Publications, 2021.

Abstract

A 59-year-old female ex-smoker with 40 pack year smoking history and a 5-year current e-cigarette (EC) use history, presented with progressive dyspnea on exertion and daily cough for 2 months. A CT scan showed a consolidation area with air bronchogram in the middle lobe and non-calcific bilateral nodules, which could be attributed to community-acquired pneumonia. The patient was treated with empiric antibiotics and systemic steroids for 10 days. Infectious, neoplastic and autoimmune pathologies were excluded, whereas a broncho-alveolar lavage revealed an accumulation of lipids in the cytoplasm of the alveolar macrophages. Despite the recommendation of vaping cessation, the patient continued to use EC. A new CT exam, carried out after 18 months, showed reversed halo sign (RHS), patchy ground-glass opacity (GGO), pleuro-parenchymal bands, and indeed perilobular pattern, suggestive of organizing pneumonia (OP). The final diagnosis was E-cigarette, or vaping, product use Associated Lung Injury (EVALI)- related OP.

Details

Language :
English
ISSN :
11220643 and 25325264
Database :
Directory of Open Access Journals
Journal :
Monaldi Archives for Chest Disease
Publication Type :
Academic Journal
Accession number :
edsdoj.4acb303c2f6841c7a2c82c6650fba809
Document Type :
article
Full Text :
https://doi.org/10.4081/monaldi.2021.1962